Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
about
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 3.Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1.Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2.Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis.Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
P2860
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Use of Oral Anticoagulation in ...... on in Patients with ESRD: Con.
@en
Use of Oral Anticoagulation in ...... on in Patients with ESRD: Con.
@nl
type
label
Use of Oral Anticoagulation in ...... on in Patients with ESRD: Con.
@en
Use of Oral Anticoagulation in ...... on in Patients with ESRD: Con.
@nl
prefLabel
Use of Oral Anticoagulation in ...... on in Patients with ESRD: Con.
@en
Use of Oral Anticoagulation in ...... on in Patients with ESRD: Con.
@nl
P2860
P356
P1476
Use of Oral Anticoagulation in ...... ion in Patients with ESRD: Con
@en
P2093
Manish M Sood
P2860
P304
P356
10.2215/CJN.03200316
P577
2016-10-25T00:00:00Z